Výsledky vyhledávání

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

Autor: H B, Rubins, S J, Robins, D, Collins, C L, Fye, J W, Anderson, M B, Elam, F H, Faas, E, Linares, E J, Schaefer, G, Schectman, T J, Wilt, J, Wittes

Publikováno v: The New England journal of medicine. 341(6)

Although it is generally accepted that lowering elevated serum levels of low-density lipoprotein (LDL) cholesterol in patients with coronary heart disease is beneficial, there are few data to guide decisions about therapy for patients whose primary l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0d2d14bf27049d3c9340b82505e6c9cd
https://pubmed.ncbi.nlm.nih.gov/10438259

Zobrazit plný text záznamu

Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients

Autor: J S, Kaufman, D J, Reda, C L, Fye, D S, Goldfarb, W G, Henderson, J G, Kleinman, C A, Vaamonde

Publikováno v: The New England journal of medicine. 339(9)

Several studies have suggested that if recombinant human erythropoietin (epoetin) is administered subcutaneously rather than intravenously, a lower dose may be sufficient to maintain the hematocrit at a given level.In a randomized, unblinded trial co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::07ce6112867dfea9edeacd4d8067ce42
https://pubmed.ncbi.nlm.nih.gov/9718384

Zobrazit plný text záznamu

Trimethoprim-sulfamethoxazole prophylaxis in granulocytopenic patients with acute leukemia: evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled Department of Veterans Affairs Cooperative Study

Autor: William A. Craig, R. G. Thomas, Robert D. Arbeit, T. T. Ward, J. B. Weinberg, R. L. Penn, C. A. Coltman, C. L. Fye, B. Chow, Sydney M. Finegold, J. Lentino, S. Ochi, B. W. Dana

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 17(3)

Despite widespread use of trimethoprim-sulfamethoxazole (TMP-SMZ) for prophylaxis in neutropenic patients, questions remain regarding its efficacy, toxicity, the risk of selection of resistant isolates, and the relation of its activity to selective d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da012fcff7b77e2e56daad002bc4dbd4
https://pubmed.ncbi.nlm.nih.gov/8218672

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání